Introduction
Heteromeric G-proteins represent one of the cell's principle means of transducing receptor-mediated intercellular communication. Go and G, are the two most diverse G-protein subfamilies. ( 1) Go consists of three Gi (Gi, -3 ) and two Go (Go*, GOB) a subunits Abbreviations used: PLC, phospholipase C; RT-PCR, reverse-transcriptase polymerase chain reaction; SCG, superior cervical ganglia; VMN, ventromedial nucleus of the hypothalamus. $To whom correspondence should be addressed. which mediate inhibition of Ca2+ currents, activation of K + currents and inhibition of adenylate cyclase. (2) G, consists of G,, GI,, G,,, G,, and G,, a subunits which mediate activation of phospholipase C (PLC) and inhibition of K& currents [ 1 4 .
In addition there are at least four p-and six ysubunits, which can also directly activate effector systems such as PLCp2, adenylate cyclase and K + currents [2, 3] .
Through use of recombinant G-protein subunits, a great deal has been revealed about the molecular make-up of the G-proteins and the iso-enzymes of adenylate cyclase and PLC with which they interact. However, most neural communication is conducted via modulation of ion-channel activity and it has rarely been demonstrated that activation of these enzymes is a prerequisite for G-proteinmediated modulation of ion-channel activity. Although it has long been suspected that the diversity of G-protein subunits will be manifest as differential coupling to either receptor and/or effector molecules, until recently there has been little direct proof for this supposition since pharmacological tools, such as pertussis toxin, can only differentiate between the Go and G, families and cannot distinguish among their individual members. More recently, studies have used antibodies and antisense DNA to identify the role of individual G, a-and B/y-subunits in signal transduction [4-81. Monospecific antibodies can uniquely distingush each member and, more importantly, can be used as functional tools to dissect involvement of individual G-protein subunits in specific pathways if the epitope to which the antibodies are directed is involved in functional coupling of the G-protein to either the receptor or effector. These studies are largely limited to single-cell studies as antibodies lend themselves well to delivery by microinjection. Using this approach, we have shown specific roles for G,, and G,,,l in signal transduction in superior cervical ganglia (SCG) neurons [8, 9] . The limitations of this approach occur when the unique epitope is either on a domain of the protein not involved with receptor or effector coupling or when such a domain is shared by more than one member of the same family (such as G, and G I I , or the two splice variants Go, and GOB). A complementary approach is to use antisense oligonucleotides to specifically knockout endogenous G-protein expression. We have used this approach to specifically knockout G, and G , , in hypothalmic neurons [6] -a feat which would have been impossible using antibodies as the C-terminal domain involved in receptor coupling is completely homologous
In the studies described here, we have identified specific Go and G,,,, a protein subunits involved in modulating ion-channel activity in primary neurons using a combination of antisense and antibody approaches. We have used two dissociated culture systems derived from rat SCG and the ventromedial nucleus of the rat hypothalamus. The relative merits of antibody and antisense approaches to the dissection of signal-transduction pathways are discussed.
[lo].
Methods

Phosphorothiolated antisense oligonucleotides ( I 8 mers)
These molecules were synthesized on an Applied Biosystems I1 oligonucleotide synthesizer at the National Instutite for Medical Research or were supplied by Genosys, Cambridge, U.K. Purity was checked by PAGE. Oligodeoxynucleotides were dissolved in serum-free growth medium (either aMEM or Dulbecco's modified Eagle's medium) and stored in aliquots at -20°C. For bath application, a final concentration of 10 or 20 ,uM was used.
Oligonucleotide sequences were as follows: G a I , 605aPT, ggtgggcaggtagcctac; G a , , 499aPT, gtagccatctgtggcgat; and G a I I 605sPT, gtaggctacctgcccacc where a refers to antisense and s refers to sense.
Antibodies
Antibodies used were anti-Ga,,,H [ 81, anti-glial
anti-Gail,, [9] and anti-Gai, [9] .
Reverse-transcriptase polymerase chain reactions
RT-PCR were carried out as described previously
. Briefly, total RNA was extracted from cells or tissue according to Chomczynski and Sacchi [ 121, treated with RQ DNAase, reverse transcribed using AMV-RT (Seikakagu) and amplified using Tuq polymerase (Promega). Primers used for amplification were: Ga, 266s, actttgggcgtggagtatggtgac; Ga,,, 883a, ggcagctgcatcttcataggtgtt; GaOH 883a, agccacagcttctgtgaaggcact; G a l , 488s, gtggaccgcatcgccacagtaggc; and Ga,,, 71 9a, tgcggttctcattgtctgactccac. Sequences were derived from [ 10, 13, 14] . Numbers refer to the first base of the sequence to which the primer corresponds relative to the adenine of the initiating ATG; s refers to sense and a refers to antisense.
(RT-PCR)
In situ hybridization This was carried out essentially as described previously [ 151. 200 g Wistar rats were perfusion fixed with 4% paraformaldehyde, processed, frozen and sectioned. Sections were hybridized with %-tailed 36-mer oligodeoxynucleotides (4 x 1 0' d.p.m./ml), washed (0.15 M NaCV10 mM NaH,PO,/l mM EDTA, pH 7.4, 5 5 T ) and exposed to Kodak Biomax film. Oligodeoxynucleotides were tailed with "S-dATP(NEN; 1500 Ci/mmol) under conditions tailored to give a median tail length of approx. 20-30 bases. All probes were examined by PAE Volume 23 prior to use. Sequences were as follows: Go,, ggggcttggtacagaaaggctgtgtgtcttaca; GOB, ctgttccacgtgtacgaggctgaagttgggt; G,, caacccacagggagggaagaaccagtttctggg; GI ,, gatgcggaggaagctggccctggtggcagccat.
Cell culture and whole-cell recording
These procedures were carried out as described previously [6, 9] .
Results and discussion
RT'PCR analysis of G-protein a-subunit gene expression Transcripts encoding G,, GI I , Go, and GO, were all detected in both SCG and forebrain. No attempt was made to quantify or compare relative levels of different amplification products.
Expression ofGq, G I I , Go, and Go, mRNA in rat brain and SCG Analysis of mRNA distribution was restricted to coronal sections of brain at the level of mid hypothalamus. Go, transcripts were prevalent in pyramidal cells of the hippocampus, granule cells of the dentate gyrus, all layers of the cerebral cortex and ventral and dorsal regions of the hypothalamus. GOB mRNA was less prevalent and expressed more evenly. G, was expressed predominantly in cortex and hippocampus, but lower levels could also be seen in hypothalamus. GI transcript levels were very low and more evenly distributed throughout the brain. No specific labelling could be seen over any white matter. G,, G I , , Go, and GOB transcripts were all present in the ganglion cell bodies of the SCG.
Unlike in brain, GI, and GOB mRNA levels were similar to G, and Go, mRNA levels.
Sense oligonucleotides showed no specific hybridization signal.
Antibody attenuation of agonist inhibition of KA and C d + currents in SCG neurons
The effects of anti-Ga antibodies and pertussis toxin on oxotremorine inhibition of K& and on noradrenaline inhibition of Ca2 + currents in dissociated SCG neurons are summarized in Tables 1 and 2 .
Data are taken from [6, 9] .
RT-PCR and in situ hybridization demonstrate the presence of G,, G I 1 , GO, and G,, transcripts in SCG and hypothalamus both in vzvo and in culture. Injection of monospecific antibodies demonstrated the involvement of G,,l I in mediating muscarinic inhibition of K& and of Go,,, in mediating noradrenergic inhibition of the Ca2+ current (Ica). Since both of these antisera were raised against a shared C-terminal epitope involved in receptor] G-protein coupling then it was not possible, using this approach, to distinguish between each homologous pair of proteins. However, immunoblots, using the same antisera, demonstrate a prevalence of G,,, in SCG membranes, supporting the notion that G,,, remains to be seen whether each of the homologous gene pairs are expressed in each cell or whether there is heterogeneity within the cell population. Such heterogeneity could be one possible explanation underlying the spectrum of efficacy of antibody injection seen in single-cell studies, which in the case of anti-GqII varied from complete abolition of the ability of 300 nM oxotremorine to attenuate K; to a total absence of effect. Specificity of antisera action can be seen from the obverse failure of the G,,, , and Gc,A,R antisera to attenuate noradrenalineand oxotremorine-induced inhibition of Ic:i and K$ respectively. Phosphorothiolated 18 mer antisense oligonucleotides, corresponding to a domain of mouse G, and G I , sharing minimum sequence identity, were used. Although, in principle, oligonucleotides derived from non-coding regions could have been used, we decided against this option as no rat sequence has been reported for either G , or GI,, and untranslated sequences are frequently poorly conserved, even across murine species. This can be seen in the case of G I I , where significant sequence divergence occurs between human, mouse and bovine 11 bp upstream of the initiation ATG codon [ 10, 16, 17] , whereas there is only one base divergence in the domain corresponding to the codingregion oligonucleotides. As can be seen from Table   2 , only antisense oligonucleotides directed against G a , , mRNA were effective in reducing I, in VMN neurons. That is not to say that Ga, subunits are not involved, since the fraction of total Ga subunits required for maximal response (i.e. the degree of spareness) is not known in this system. These studies have thus allowed us to identify G a proteins involved in agonist modulation of K + currents involved in regulating neuronal excitability and of Ca2+ currents that may play a role in regulation of neurotransmitter release.
I40
Antibody versus antisense *roaches
Strengths of the antibody approach are the acute interference with the receptor-G-protein interaction, ease of injection for single-cell studies, and ability to use in broken-cell studies. Drawbacks include the requirement to produce a monospecific antiserum against a unique epitope that is involved in receptor-G-protein coupling and the difficulty in introducing antibody to populations of cells. Antibodies rarely achieve complete abolition of an in vitro response -a feature which is shared with antisense oligonucleotides. Antisense approaches offer the potential advantage of targeting any transcript uniquelysince problems can be made against highly nonconserved untranslated regions, even speciesspecific probes can be made. This is particularly useful, when the full extent and degree of homology of a particular gene subfamily are unknown. Multiple probes corresponding to different domains of the transcript enable specificity of action to be verified. A major disadvantage is that antisense probes are essentially metabolic blockers and therefore their use is dependent upon the tl,L of the mRNA and, in particular, the protein, consequently there is little potential for complete abolition of the response. However, as postulated by Kleuss et al.
[ 51, even these half-lives may be subject to homoeostatic feedback in oligonucleotide-treated cells. This latter point is exacerbated by the short half-life of oligonucleotides both intracellularly and in tissueculture growth medium. If intracellular injection is elected for, then another consequence of the latency between administration and analysis is the requirement for the cell to be sufficiently robust to withstand initial impalement by an injection electrode followed several days later by a recording electrode. Another factor to consider is the directness of involvement of the protein encoded by the targeted transcript as the longer the incubation period, the greater the potential for such effects to be downstream of the targeted gene product. Ultimately, the strength of the antisense approach lies in its ability to target individual tran-
Introduction
The uptake and processing of information from the surroundings by all cells is mediated by a number of protein components in their plasma membrane. These include surface receptors which recognize physical or chemical messengers from the outside such as light, hormones, neurotransmitters, growth factors or odorants, and transmit these signals to effectors. These effector molecules, usually membrane-associated, release chemical second messengers which exert specific actions on target enzymes inside the cell. The link between receptors and effectors is in many cases mediated by hetero-
Abbreviations used: BARK, B-adrenergic receptor kinase; GRK, G-protein-coupled receptor kinase; MAPK, mitogen-activated protein kinase; PI3K, phosphoinositide 3-kinase; RK, rhodopsin kinase. *To whom correspondence should be addressed.
trimeric GTP-binding proteins. These G proteins are crucial for the specificity, velocity and amplification of the signal transduction across membranes.
The switching function of G proteins
Heterotrimeric G proteins consist of three different subunits: an a subunit (39-52kDa), a / 3 subunit (35/36 kDa) and a y subunit (6-8 m a ) . Depending on the nucleotide bound to the a subunit, G proteins can switch between an active and an inactive form. The GTP-binding state represents the active form which is stable to activate directly diverse effectors. The intrinsic GTPase function of the Q subunit hydrolyses GTP to GDP and thereby induces the GDP-binding inactive form. This state is stabilized by association of the a subunit with the tightly bound complex of / 3 and y subunits. The receptors of the family characterized by seven transmembrane-spanning helices catalyse in their agonist-bound active conformation (e.g. light-acti-
